Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-17-032206
Filing Date
2017-05-12
Accepted
2017-05-12 19:48:30
Documents
1
Period of Report
2017-05-11

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 6147
  Complete submission text file 0001209191-17-032206.txt   7442
Mailing Address 7555 GATEWAY BLVD. NEWARK CA 94560
Business Address 7555 GATEWAY BLVD. NEWARK CA 94560 510-742-3400
Revance Therapeutics, Inc. (Issuer) CIK: 0001479290 (see all company filings)

EIN.: 770551645 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 2525 DUPONT DRIVE IRVINE CA 92612
Business Address
Gangolli Julian S (Reporting) CIK: 0001532023 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36297 | Film No.: 17840651